During the past decade, Radiant Research Inc (Minneapolis) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Radiant Research Inc (Minneapolis)" are "Type 2 Diabetes" (2 trials), "Diabetes Type 2" (1 trials), "Diabetes, Type I" (1 trials) and "Type 1 Diabetes" (1 trials). Many other conditions were trialed in "Radiant Research Inc (Minneapolis)" in a lesser frequency.

Most popular intervention types in "Radiant Research Inc (Minneapolis)" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Technosphere® Insulin Inhalation Powder" (2 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "Active comparator" (1 trials), "Comparator" (1 trials) and "Insulin Aspart" (1 trials). Other intervention names were less common.

The vast majority of trials in "Radiant Research Inc (Minneapolis)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Radiant Research Inc (Minneapolis)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Radiant Research Inc (Minneapolis), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Radiant Research Inc (Minneapolis), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".